Loggia Nicoletta bought CADL
September 30, 2026 · Form 4 insider transaction
Loggia Nicoletta bought 380 shares of Candel Therapeutics, Inc. at $8.68 per share, a transaction worth $3.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
380
Price
$8.68
Total value
$3.3K
InsiderLoggia Nicoletta
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 30, 2026
Filing dateOctober 2, 2026
Shares owned after380
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant.